395 related articles for article (PubMed ID: 30547786)
1. Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver disease.
Breher-Esch S; Sahini N; Trincone A; Wallstab C; Borlak J
BMC Med Genomics; 2018 Dec; 11(1):111. PubMed ID: 30547786
[TBL] [Abstract][Full Text] [Related]
2. Genomics of human fatty liver disease reveal mechanistically linked lipid droplet-associated gene regulations in bland steatosis and nonalcoholic steatohepatitis.
Sahini N; Borlak J
Transl Res; 2016 Nov; 177():41-69. PubMed ID: 27376874
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible lipid droplet-associated induces DGAT1 and promotes lipid storage in hepatocytes.
de la Rosa Rodriguez MA; Deng L; Gemmink A; van Weeghel M; Aoun ML; Warnecke C; Singh R; Borst JW; Kersten S
Mol Metab; 2021 May; 47():101168. PubMed ID: 33465519
[TBL] [Abstract][Full Text] [Related]
4. Modeling Nonalcoholic Fatty Liver Disease with Human Pluripotent Stem Cell-Derived Immature Hepatocyte-Like Cells Reveals Activation of PLIN2 and Confirms Regulatory Functions of Peroxisome Proliferator-Activated Receptor Alpha.
Graffmann N; Ring S; Kawala MA; Wruck W; Ncube A; Trompeter HI; Adjaye J
Stem Cells Dev; 2016 Aug; 25(15):1119-33. PubMed ID: 27308945
[TBL] [Abstract][Full Text] [Related]
5. Differential capability of metabolic substrates to promote hepatocellular lipid accumulation.
Hoang NA; Richter F; Schubert M; Lorkowski S; Klotz LO; Steinbrenner H
Eur J Nutr; 2019 Dec; 58(8):3023-3034. PubMed ID: 30368556
[TBL] [Abstract][Full Text] [Related]
6. Lipid droplets interact with mitochondria using SNAP23.
Jägerström S; Polesie S; Wickström Y; Johansson BR; Schröder HD; Højlund K; Boström P
Cell Biol Int; 2009 Sep; 33(9):934-40. PubMed ID: 19524684
[TBL] [Abstract][Full Text] [Related]
7. Biomechanics of cultured hepatic cells during different steatogenic hits.
Baldini F; Bartolozzi A; Ardito M; Voci A; Portincasa P; Vassalli M; Vergani L
J Mech Behav Biomed Mater; 2019 Sep; 97():296-305. PubMed ID: 31151002
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol Ameliorates Lipid Droplet Accumulation in Liver Through a SIRT1/ ATF6-Dependent Mechanism.
Zhou R; Yi L; Ye X; Zeng X; Liu K; Qin Y; Zhang Q; Mi M
Cell Physiol Biochem; 2018; 51(5):2397-2420. PubMed ID: 30537742
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG
Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005
[TBL] [Abstract][Full Text] [Related]
10. Differential Roles of Cell Death-inducing DNA Fragmentation Factor-α-like Effector (CIDE) Proteins in Promoting Lipid Droplet Fusion and Growth in Subpopulations of Hepatocytes.
Xu W; Wu L; Yu M; Chen FJ; Arshad M; Xia X; Ren H; Yu J; Xu L; Xu D; Li JZ; Li P; Zhou L
J Biol Chem; 2016 Feb; 291(9):4282-93. PubMed ID: 26733203
[TBL] [Abstract][Full Text] [Related]
11. Reactive Oxygen Species Induces Lipid Droplet Accumulation in HepG2 Cells by Increasing Perilipin 2 Expression.
Jin Y; Tan Y; Chen L; Liu Y; Ren Z
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400205
[TBL] [Abstract][Full Text] [Related]
12. A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis.
Parafati M; Kirby RJ; Khorasanizadeh S; Rastinejad F; Malany S
Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30254132
[TBL] [Abstract][Full Text] [Related]
13. Models of non-Alcoholic Fatty Liver Disease and Potential Translational Value: the Effects of 3,5-L-diiodothyronine.
Grasselli E; Canesi L; Portincasa P; Voci A; Vergani L; Demori I
Ann Hepatol; 2017; 16(5):707-719. PubMed ID: 28809727
[TBL] [Abstract][Full Text] [Related]
14. A unifying mathematical model of lipid droplet metabolism reveals key molecular players in the development of hepatic steatosis.
Wallstab C; Eleftheriadou D; Schulz T; Damm G; Seehofer D; Borlak J; Holzhütter HG; Berndt N
FEBS J; 2017 Oct; 284(19):3245-3261. PubMed ID: 28763157
[TBL] [Abstract][Full Text] [Related]
15. Effects of
Mun J; Park J; Yoon HG; You Y; Choi KC; Lee YH; Kim K; Lee J; Kim OK; Jun W
J Med Food; 2019 Dec; 22(12):1262-1270. PubMed ID: 31834842
[TBL] [Abstract][Full Text] [Related]
16. Long Non-Coding RNAs Involved in Progression of Non-Alcoholic Fatty Liver Disease to Steatohepatitis.
Atanasovska B; Rensen SS; Marsman G; Shiri-Sverdlov R; Withoff S; Kuipers F; Wijmenga C; van de Sluis B; Fu J
Cells; 2021 Jul; 10(8):. PubMed ID: 34440652
[TBL] [Abstract][Full Text] [Related]
17. Moderate Treadmill Exercise Alleviates NAFLD by Regulating the Biogenesis and Autophagy of Lipid Droplet.
Yang Y; Li X; Liu Z; Ruan X; Wang H; Zhang Q; Cao L; Song L; Chen Y; Sun Y
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432597
[TBL] [Abstract][Full Text] [Related]
18. Lipid accumulation stimulates the cap-independent translation of SREBP-1a mRNA by promoting hnRNP A1 binding to its 5'-UTR in a cellular model of hepatic steatosis.
Siculella L; Tocci R; Rochira A; Testini M; Gnoni A; Damiano F
Biochim Biophys Acta; 2016 May; 1861(5):471-81. PubMed ID: 26869449
[TBL] [Abstract][Full Text] [Related]
19. The role of hepassocin in the development of non-alcoholic fatty liver disease.
Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
[TBL] [Abstract][Full Text] [Related]
20. Alpha-naphthoflavone attenuates non-alcoholic fatty liver disease in oleic acid-treated HepG2 hepatocytes and in high fat diet-fed mice.
Xia H; Zhu X; Zhang X; Jiang H; Li B; Wang Z; Li D; Jin Y
Biomed Pharmacother; 2019 Oct; 118():109287. PubMed ID: 31401392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]